Cyclosporine* (Cyclosporine) — Medicare Part D spending
Multiple manufacturers (6) · Rank #189 by total Part D spend · CMS data year 2023
Medicare Part D spent $255,901,494 on Cyclosporine* (Cyclosporine) in 2023, the #189 drug by total Part D spending out of 3,598 drugs. That worked out to about $5.66 per dosage unit, $542 per claim and $1,356 per beneficiary, across 472,423 claims for 188,711 beneficiaries. Average spending per dosage unit fell -14.4% from 2022. These are aggregate Medicare program figures (gross drug cost), not the price you pay.
Source: CMS Medicare Part D Spending by Drug (data year 2023). Data as of June 2026.
Cyclosporine* (Cyclosporine) spending at a glance (2023)
| Metric | Cyclosporine* (Cyclosporine) |
|---|---|
| Total Part D spending (2023) | $255,901,494 |
| Total spending (2022) | $112,994,238 |
| Year-over-year change in total spending | +126.5% |
| Average spending per dosage unit (2023) | $5.66 |
| Change in spend per dosage unit (YoY) | -14.4% |
| Avg annual change per dosage unit (2019-2023 CAGR) | -0.7% |
| Average spending per claim (2023) | $542 |
| Average spending per beneficiary (2023) | $1,356 |
| Total claims (2023) | 472,423 |
| Beneficiaries (2023) | 188,711 |
| Total dosage units (2023) | 45,429,930 |
| Manufacturer(s) | Multiple manufacturers (6) |
| National rank by total spend (of 3,598 drugs) | #189 |
Source: CMS Medicare Part D Spending by Drug (data year 2023). Data as of June 2026.
2022 vs 2023
| Metric | 2022 | 2023 | Change |
|---|---|---|---|
| Total spending | $112,994,238 | $255,901,494 | +126.5% |
| Avg spend per dosage unit | $6.61 | $5.66 | -14.4% |
| Avg spend per claim | $601 | $542 | — |
| Avg spend per beneficiary | $1,169 | $1,356 | — |
| Total claims | 188,162 | 472,423 | — |
| Beneficiaries | 96,639 | 188,711 | — |
How Cyclosporine* compares with nearby drugs
Drugs with total Part D spending closest to Cyclosporine* (Cyclosporine):
| Drug (rank) | Total spend 2023 | Per dosage unit | Per-unit YoY |
|---|---|---|---|
| Cyclosporine* (Cyclosporine) (this drug, #189) | $255,901,494 | $5.66 | -14.4% |
| Strensiq (Asfotase Alfa) (#187) | $258,940,106 | $6,180.92 | -0.9% |
| Humira (Adalimumab) (#188) | $257,644,313 | $3,568.20 | +11.4% |
| Xolair (Omalizumab) (#190) | $254,056,609 | $1,363.73 | +7.7% |
| Xtampza ER (Oxycodone Myristate) (#191) | $250,042,795 | $11.75 | +4.8% |
| Metformin HCl (#192) | $247,531,906 | $0.0723 | +26.7% |
Frequently asked questions
How much does Medicare Part D spend on Cyclosporine*?
Medicare Part D spent $255,901,494 on Cyclosporine* (Cyclosporine) in 2023 (the latest CMS data year), across 472,423 claims for 188,711 beneficiaries. That ranks #189 of 3,598 drugs by total Part D spending. This is gross drug cost (Medicare, plan and beneficiary payments combined), not the price you personally pay.
What is the average spending per dosage unit for Cyclosporine*?
In 2023, the weighted average Medicare Part D spending per dosage unit for Cyclosporine* (Cyclosporine) was $5.66. Compared with 2022 it fell -14.4%. A "dosage unit" is one pill, tablet, milliliter or other billing unit, so this is not the price of a prescription.
Who makes Cyclosporine*?
CMS attributes Cyclosporine* (Cyclosporine) to Multiple manufacturers (6) in the 2023 Part D spending file. Average spending per claim was $542 and per beneficiary $1,356.
Is the Cyclosporine* figure the price I pay?
No. These are aggregate Medicare Part D program figures (total gross drug cost and averages across all claims), published by CMS for transparency. Your out-of-pocket cost depends on your plan, formulary, deductible and coverage phase. Always check your plan and talk to your pharmacist or doctor.
Keep exploring
Source & what this means
Figures are from the CMS Medicare Part D Spending by Drug dataset (data year 2023, US public domain). "Total spending" is the gross drug cost — Medicare, plan and beneficiary payments combined — for Part D claims; it is not a list price, a negotiated price, or what any individual pays. Spending per dosage unit is volume-weighted across formulations. This is general public-spending information, not medical or pricing advice. Your own cost depends on your plan, deductible and coverage phase — verify with your Part D plan and a pharmacist. Data as of June 2026. See our methodology and disclaimer.
Last updated: 2026-06-20